Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

DNLIDNLI
17 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in DENALI THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 4.2M shares of DNLI (DENALI THERAPEUTICS INC), worth $106.9M as of 2026-Q2. The position was decreased (-5.7% shares). DNLI represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$106.9M

Current Shares

4.2M

Total Value Change

+$106.9M

Total Shares Change

+3.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4.2M
-5.7%
$106.9M0.0%$25.72
0
2026-Q1
Increased
4.4M
+14.9%
$84.6M0.0%$20.02
34
2025-Q4
Increased
3.8M
+77.3%
$63.3M0.0%$16.41
45
2025-Q3
Increased
2.2M
+16.0%
$31.4M0.0%$14.52
33
2025-Q2
Increased
1.9M
+11.6%
$26.1M0.0%$14.10
32
2025-Q1
Increased
1.7M
+58.1%
$22.7M0.0%$14.78
41
2024-Q4
Decreased
1.1M
-22.7%
$21.6M0.0%$20.38
0
2024-Q3
Increased
1.4M
+12.2%
$39.8M0.0%$29.13
33
2024-Q2
Increased
1.2M
+34.8%
$28.3M0.0%$23.22
37
2024-Q1
Increased
904,361
+129.7%
$18.6M0.0%$20.52
46
2023-Q4
Decreased
393,805
-3.3%
$8.5M0.0%$21.46
0
2023-Q3
Decreased
407,393
-36.8%
$8.4M0.0%$20.63
0
2023-Q2
Increased
644,914
+12.6%
$19M0.0%$29.51
32
2023-Q1
Decreased
572,843
-25.7%
$13.2M0.0%$23.04
0
2022-Q4
Increased
771,452
+5.9%
$21.5M0.0%$27.81
30
2022-Q3
Increased
728,272
+73.1%
$22,3520.0%$30.69
28
2022-Q2
First report
420,742
-
$12,3820.0%$29.43
0

Other major holders of DNLI: BAILLIE GIFFORD & CO, BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used